| Errors | Missing | Unverified | Supported |
|---|---|---|---|
| 0 | 1 | 0 | 14 |
The financial performance of Birds of Prey (and the Fantabulous Emancipation of One Harley Quinn) is often characterized as a "box-office disappointment" that likely found financial stability only after transitioning to digital and home media platforms.
The film's theatrical run was cut short by the onset of the COVID-19 pandemic in March 2020. Despite positive reviews (78% on Rotten Tomatoes), it struggled to attract the same massive audience as previous DC films.
Context: The film opened with $33 million domestically, significantly lower than the projected $50–$55 million. For comparison, the 2016 Suicide Squad (in which Harley Quinn debuted) opened to $133.7 million and grossed over $746 million worldwide.
Because theaters closed shortly after the film's release, Warner Bros. moved the film to "Premium Video on Demand" (PVOD) on March 24, 2020—just over a month after its theatrical debut—charging $19.99 for a 48-hour rental.
Determining the film's exact profitability is complex due to marketing costs and the shortened theatrical window.
| Metric | Figure |
|---|---|
| Total Production Budget (Net) | ~$84.5 million |
| Total Box Office Revenue | $205.5 million |
| Theatrical Break-Even Point | $250M – $300M |
| Est. Net Position | Theatrical Loss / Ancillary Break-Even |
Conclusion: On a purely theatrical basis, Birds of Prey was a loss for the studio, falling roughly $50–$100 million short of its break-even target. However, once the $31M+ in physical sales and significant PVOD revenue are factored in, most analysts believe the film eventually reached a "break-even" or slightly profitable status over the long term, though it remained the lowest-grossing entry in the DC Extended Universe (DCEU) at the time.
The summary omits that major theater chains (AMC, Regal, Cinemark) changed the display title to 'Harley Quinn: Birds of Prey' during the theatrical run in an attempt to boost ticket sales by emphasizing the main character. This is a notable detail regarding its box office 'struggle'.
The AI Summary is highly accurate and well-supported by trade data. It correctly identifies the film as a theatrical disappointment ($205.5M worldwide against a $250-300M break-even point) that likely recovered through strong ancillary revenue (PVOD, Physical Media). The specific figures for box office ($84.2M Dom / $121.3M Int), budget ($84.5M Net), and physical sales ($31.2M) are precise. The context regarding the COVID-19 impact and the subsequent pivot to PVOD is also correct.